Several big biotech stocks have proven to be big winners for investors in recent years. Celgene (NASDAQ: CELG) and Amgen (NASDAQ: AMGN) definitely belong in that category. In the last five years, Celgene’s share price has more than tripled, while Amgen stock is up over 140%.
But which of these biotech stocks is the better buy for investors now? Here’s how Celgene and Amgen compare.
Image source: Getty Images.